Healthy Extracts (HYEX) AI Stock Analysis

• Market Cap: $5.96M
• Dividend Yield: N/A
• Average Volume (3M): 892.00
• Price to Earnings (P/E): ―
• Beta (1Y): 0.92
• Revenue Growth: 25.24%
• EPS Growth: 66.44%
• Country: US
• Employees: 2
• Sector: Healthcare
• Sector Strength: 40
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.13
• Shares Outstanding: 3,136,906
• 10 Day Avg. Volume: 625
• 30 Day Avg. Volume: 892
• PEG Ratio: 0.25
• Price to Book (P/B): 7.29
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -39.95
• Enterprise Value/Market Cap: 0.99
• Enterprise Value/Revenue: 0.48
• Enterprise Value/Gross Profit: 3.05
• Enterprise Value/Ebitda: -2.00
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 56 Neutral
• Price Target: ―

Healthy Extracts' stock reflects a moderate score driven primarily by its financial performance and technical analysis. While the company shows revenue growth potential, persistent profitability challenges and high leverage are significant risks. The stock's technical indicators suggest a bullish trend, but overbought conditions warrant caution. The negative P/E ratio and lack of dividends further impact the overall score.

Healthy Extracts Business Overview & Revenue Model

Company Description

Healthy Extracts (HYEX) is a company focused on developing and marketing plant-based products for health and wellness. The company operates in the nutraceutical sector, offering a range of products that aim to support cognitive function, heart health, and overall well-being. Their core products include proprietary formulations derived from natural ingredients, designed to enhance physical and mental performance.

How the Company Makes Money

Healthy Extracts makes money primarily through the sale of its nutraceutical products. The company generates revenue by selling directly to consumers through its e-commerce platform and by distributing its products through various retail and online channels. Key revenue streams include the sales of their branded supplements and custom formulations. The company also benefits from strategic partnerships with other health and wellness brands, which help expand its distribution network and increase product visibility. Additionally, Healthy Extracts may engage in licensing agreements for their proprietary formulations, providing another revenue source.

Healthy Extracts Financial Statement Overview

Summary

Healthy Extracts shows potential in revenue growth, yet struggles with profitability and financial leverage. The improvement in cash flow is promising, but the persistent negative earnings and high leverage present ongoing risks.

Income Statement

Healthy Extracts has shown a significant improvement in revenue over the years, with a notable revenue growth from 2023 to 2024. However, the company still struggles with profitability, reporting a negative net income and EBIT consistently, indicating ongoing operational challenges. While gross profit margins are positive, the persistent negative net profit margins highlight the difficulty in converting sales to profit.

Balance Sheet

The company's balance sheet indicates a high level of debt relative to equity, with a concerning debt-to-equity ratio that reflects financial leverage risks. Despite this, the equity ratio is positive, suggesting some degree of financial stability. Nonetheless, the declining stockholders' equity over recent years poses a risk to financial health.

Cash Flow

Cash flow statements reveal an improvement in operating cash flow with a positive free cash flow in the latest year, marking a positive shift from previous periods of negative cash flow. However, the cash flow to net income ratio remains unfavorable due to the negative net income, indicating challenges in translating operational success to bottom-line profitability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.36M	3.11M	2.49M	2.25M	1.47M	1.28M
Gross Profit	1.93M	1.91M	1.62M	1.37M	695.08K	-578.44K
EBITDA	-54.91K	-183.15K	-2.24M	-910.71K	-1.89M	-2.49M
Net Income	-377.82K	-840.67K	-2.47M	-989.96K	-2.04M	-2.65M
Balance Sheet
Total Assets	2.41M	2.38M	2.64M	2.78M	3.03M	3.12M
Cash, Cash Equivalents and Short-Term Investments	118.80K	112.02K	19.44K	65.65K	222.10K	59.20K
Total Debt	1.08M	941.90K	1.13M	593.52K	342.62K	177.62K
Total Liabilities	2.35M	1.97M	1.68M	902.79K	558.84K	261.61K
Stockholders Equity	60.51K	410.38K	954.59K	1.88M	2.47M	2.85M
Cash Flow
Free Cash Flow	323.26K	281.97K	-415.75K	-342.95K	-997.30K	-3.49M
Operating Cash Flow	323.26K	281.97K	-415.75K	-334.96K	-901.30K	-3.48M
Investing Cash Flow	0.00	0.00	0.00	-7.99K	-96.00K	-425.88K
Financing Cash Flow	-291.78K	-189.39K	369.54K	239.52K	1.16M	3.83M

Healthy Extracts Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HYEX, the sentiment is Neutral. The current price of 1.9 is below the 20-day moving average (MA) of 1.92, below the 50-day MA of 2.52, and below the 200-day MA of 2.36, indicating a neutral trend. The MACD of -0.16 indicates Negative momentum. The RSI at 48.97 is Neutral, neither overbought nor oversold. The STOCH value of 88.72 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HYEX.

Healthy Extracts Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HYEX	56 Neutral	$5.96M	―	-356.18%	―	25.24%	66.44%
Sector *	51 Neutral	$7.50B	0.32	-61.87%	2.27%	17.10%	1.59%
COSM	42 Neutral	$12.18M	―	-58.30%	―	―	―
FLGC	42 Neutral	$13.42M	―	-336.65%	―	-28.78%	86.97%
TLPH	41 Neutral	$9.25M	―	-106.83%	―	-100.00%	65.76%
CPHI	41 Neutral	$5.90M	―	-59.14%	―	-33.10%	71.37%